People News: Sepracor and inVentiv

Share this article:
Sepracor president, CEO and director Adrian Adams resigned ahead of the company's absorption by Dainippon Sumitomo Pharma Co. He will be replaced by Saburo Hamanaka, a former head of Takeda's US operations who becomes chairman of Sepracor. The merger of Dainippon Sumitomo Pharma's US subsidiary into Sepracor will be completed April 1.

inVentiv Health named former Pfizer exec Eric Sirota president of commercial services. Sirota, most recently VP US marketing, commercial strategy and innovation and regional sales within Pfizer's Powers business unit, will oversee inVentiv's Selling Solutions and Advance Insights divisions and will report to CEO Blane Walter.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters